Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

 ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announced the publication of a study by the Cureus Journal of Medical Science, in which the Company’s precision oral appliance therapy (OAT) devices successfully treated patients’ OSA.

“The study underscored what we see daily in our practice at Star Sleep & Wellness. Our team continues to favor the ProSomnus® EVO® Sleep and Snore Device, as it not only garners the fewest number of patient complaints regarding fit and comfort, but also shows to be superior in resolving chief complaints such as partner discontent, fatigue and daytime sleepiness,” said Dr. Kent Smith, D-ABDSM, ASBA, a co-author of the study.

https://www.globenewswire.com/news-release/2023/12/19/2798494/0/en/Data-Published-by-Cureus-Journal-of-Medical-Science-Shows-Successful-Treatment-of-Obstructive-Sleep-Apnea-with-ProSomnus-Precision-Oral-Appliance-Devices.html